Physician

Gina Charlene Ang, MD

According to 2025 Medicare claims, Gina Ang, MD (NPI: 1396853966) practices dermatology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Ottawa, MI. This provider's primary affiliated billing organization is JACK A DEKKINGA MD PC (NPI: 1609896034; TIN: 382561981) and primary practice location at 49418-3076.

Ang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 318 traditional Medicare patients, billed 1,189 HCPCS/CPT codes, and received $165,836 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 217 prescription claims across 165 beneficiaries totaling $2,671 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 5 records totaling $128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $376,363 to $165,836. Similarly, Part D prescription costs have declined steadily, from $61,506 to $2,671. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$215K$431K2015 Medicare payment: $376,363 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $430,589 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $351,459 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $347,475 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $358,003 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $312,680 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $318,882 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $248,080 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $164,947 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $165,836 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155282,282$376,363
20164912,186$430,589
20174021,717$351,459
20184047,644$347,475
20193882,576$358,003
20203301,880$312,680
20214411,919$318,882
20224221,681$248,080
20232641,039$164,947
20243181,189$165,836

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$42K$85K2015 Drug cost: $61,506 (USD; Tot_Drug_Cst)2016 Drug cost: $26,324 (USD; Tot_Drug_Cst)2017 Drug cost: $80,715 (USD; Tot_Drug_Cst)2018 Drug cost: $84,599 (USD; Tot_Drug_Cst)2019 Drug cost: $30,122 (USD; Tot_Drug_Cst)2020 Drug cost: $13,558 (USD; Tot_Drug_Cst)2021 Drug cost: $37,316 (USD; Tot_Drug_Cst)2022 Drug cost: $7,616 (USD; Tot_Drug_Cst)2023 Drug cost: $4,867 (USD; Tot_Drug_Cst)2024 Drug cost: $2,671 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015489745$61,506
2016282425$26,324
2017386676$80,715
2018430759$84,599
2019304476$30,122
2020306426$13,558
2021342467$37,316
2022262334$7,616
2023181232$4,867
2024165217$2,671

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks143183$469
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more120131$61
11102Biopsy of related skin growth, first growth5154$56
17000Destruction of precancer skin growth, 1 growth102119$33
17003Destruction of precancer skin growth, 2-14 growths72293$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil13463$584
MupirocinMupirocin961,805$558
ImiquimodImiquimod23720$497
CephalexinCephalexin18125$126
Doxycycline HyclateDoxycycline Hyclate19284$109

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$128Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gina Charlene Ang, MD?

Tedicare shows public-source Medicare data for Gina Charlene Ang, MD (NPI 1396853966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gina Charlene Ang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gina Charlene Ang, MD?

Gina Charlene Ang, MD is linked to JACK A DEKKINGA MD PC (billing NPI 1609896034) in the available physician profile data.

Does Gina Charlene Ang, MD have Open Payments data?

Gina Charlene Ang, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.